Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if bortezomib when given in combination
with cyclophosphamide and rituximab can help to control mantle cell lymphoma. The safety of
this drug combination will also continue to be studied.